Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SESN

Sesen Bio (SESN) Stock Price, News & Analysis

Sesen Bio logo

About Sesen Bio Stock (NASDAQ:SESN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.63
$12.99
52-Week Range
N/A
Volume
93,330 shs
Average Volume
1.07 million shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

SESN Stock News Headlines

Trey Mewes
Sesen Bio (NASDAQ: SESN)
Only a handful of people know the setup that's defied these chaotic markets.
Since February, we've hit 28 out of 29 trades – that's a 96% win rate taking simple options setups on one single ticker every day. That's why Jack Carter and I teamed up to reveal The 4PM Payout Plan. Our goal here was to show you how to take these daily setups every morning to collect a 4PM payout. Naturally, no one can guarantee what the market does in the future… But these simple daily options setups have paid out with the market rallying, dropping, or staying flat. And if you want to be one of the few to not just know the ropes behind these daily setups but also deploy them for yourself…
See More Headlines

SESN Stock Analysis - Frequently Asked Questions

Sesen Bio, Inc. (NASDAQ:SESN) posted its earnings results on Sunday, November, 7th. The company reported $7.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.40) by $8.60.

Sesen Bio's stock reverse split before market open on Wednesday, March 8th 2023. The 1-20 reverse split was announced on Wednesday, March 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sesen Bio investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), NIO (NIO), Bank of America (BAC), Wells Fargo & Company (WFC) and OPKO Health (OPK).

Company Calendar

Last Earnings
11/07/2021
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SESN
Employees
35
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.88 million
Pretax Margin
-59.40%

Debt

Sales & Book Value

Annual Sales
$40 million
Price / Cash Flow
3.39
Book Value
$0.78 per share
Price / Book
N/A

Miscellaneous

Free Float
196,980,000
Market Cap
$2.56 billion
Optionable
Optionable
Beta
0.83
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:SESN) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners